The Keystone State is surrounded by Green.
24 states have now approved adult-use marijuana and while Pennsylvania isn’t one of them, residents will have plenty of options right across state lines. With Ohio green, the commonwealth is surrounded by canna-crazed states, including New York, New Jersey, Delaware and Maryland.
As the state loses ground to its neighbors in the race to capitalize on legalization, two politicians are stepping up. State Sens. Dan Laughlin, a Republican from Erie, and Sharif Street, a Dem from Philly, have introduced a bipartisan regulatory framework aimed at sparking
fatties conversations around legalization.
‘Cannabis legalization is inevitable,’ or so says a group of policy analysts, and we’ll walk through the current shots on goal across all three branches of the U.S. gov’t. “It’s inevitable,” says Jaret Seiberg, an analyst at TD Cowen, “It’s just a question of how bumpy the next several years are going to be.”
We like to highlight the potential efficacy of cannabis across numerous indications—we built this repository ICYMI—and we’ll be adding to that collection after today as we share several new studies on eczema, psoriasis, acne, pruritus, hair disorders, skin cancer and neuroinflammation.
The U.S canna pre-election set-up remains in place although some of that sequencing may have shifted, if our latest intelligence is on point. We’ll dig into those specifics, chew through the price action, highlight a fresh initiation and sniff at the ‘other side’ of some conspicuous insider selling from a top-tier U.S. operator.
All that and more, just scroll down.